GSK plc (GSK) ORD GBP0.3125

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Berenberg downgrades GSK to 'hold' ahead of product rollouts
3 June 2025 10:18
(Sharecast News) - Analysts at Berenberg downgraded drugmaker GSK from 'buy' to 'hold' on Tuesday as it awaited upcoming product launches.
-
GSK's linerixibat to be reviewed by US FDA
2 June 2025 07:40
(Sharecast News) - Drugmaker GSK revealed on Monday that a new drug application for its linerixibat asset had been accepted for review by the US Food and Drug Administration for use in cholestatic pruritus...
-
GSK, Spero UTI drug trial ends early after meeting target
28 May 2025 13:19
(Sharecast News) - UK pharma giant GSK and its partner Spero Therapeutics on Wednesday said it had ended a late-stage trial of an experimental drug for complicated urinary tract infections early after it met...
-
GSK's COPD treatment approved by FDA
23 May 2025 07:20
(Sharecast News) - Pharma group GSK has announced that US regulators have approved for use its Nucala treatment for adults with chronic obstructive pulmonary disease (COPD) following positive results from...
-
GSK's blood cancer treatment approved in Japan
19 May 2025 07:41
(Sharecast News) - GSK's Blenrep treatment has been approved by Japanese regulators when in combination for relapsed or refractory multiple myeloma, marking the second major approval of its kind for the...
-
London close: Stocks finish choppy week in the black
16 May 2025 16:32
(Sharecast News) - London equities ended the week higher on Friday, supported by gains in pharmaceutical and energy stocks.
-
GSK buys Boston's developmental liver disease drug for up to $2bn
14 May 2025 07:18
(Sharecast News) - GSK announced on Wednesday that it has entered into an agreement with Boston Pharmaceuticals to acquire its lead asset Efimosfermin for up to $2bn, buying a specialty medicine to treat and...
-
Pharma stocks slide as Trump threatens price cuts in US
12 May 2025 10:13
(Sharecast News) - Shares in pharmaceutical companies fell on Monday after US President Donald Trump threatened to sign an executive order to slash the price of prescription drugs for Americans.
-
Sunday newspaper round-up: US-China, Aerospace, Pharma
11 May 2025 14:38
(Sharecast News) - The US president said talks with China that were taking place in Geneva had achieved a "total reset" in the two countries' trade relations. Without elaborating, Donald Trump...
-
London close: FTSE snaps 16-day win streak ahead of Fed
7 May 2025 15:05
(Sharecast News) - London stocks ended lower on Wednesday, with the top-flight index snapping a 16-day winning streak as investor caution ahead of the US Federal Reserve's policy decision weighed on...
-
GSK, AstraZeneca slide after FDA unveils new vaccine lead
7 May 2025 11:32
(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.
-
GSK's Nucala delivers positive outcomes in published trial results
1 May 2025 09:54
(Sharecast News) - GSK announced on Thursday that its monoclonal antibody 'Nucala', or mepolizumab, delivered a statistically significant and clinically meaningful reduction in exacerbations for...
Company announcements Announcements
-
Transaction in Own Shares
6 June 2025 07:00
GSK
-
Transaction in Own Shares
5 June 2025 07:00
GSK
-
GSK - second tranche of share buyback programme
4 June 2025 07:00
GSK
-
Transaction in Own Shares
4 June 2025 07:00
GSK
-
Transaction in Own Shares
3 June 2025 07:00
GSK
-
Director/PDMR Shareholding
2 June 2025 15:30
GSK
-
Total Voting Rights
2 June 2025 15:00
GSK
-
Linerixibat file accepted for review by US FDA
2 June 2025 07:00
GSK
-
Transaction in Own Shares
2 June 2025 07:00
GSK
-
Transaction in Own Shares
30 May 2025 07:00
GSK
-
Transaction in Own Shares
29 May 2025 07:00
GSK
-
GSK stops Phase 3 trial on cUTIs for efficacy
28 May 2025 12:00
GSK
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.